These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 17163240)

  • 21. The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?
    Hays RD; Woolley JM
    Pharmacoeconomics; 2000 Nov; 18(5):419-23. PubMed ID: 11151395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation.
    Chung M; Vashi V; Puente J; Sweeney M; Meredith P
    Br J Clin Pharmacol; 1999 Nov; 48(5):678-87. PubMed ID: 10594469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-attribute health status classification systems. Health Utilities Index.
    Feeny D; Furlong W; Boyle M; Torrance GW
    Pharmacoeconomics; 1995 Jun; 7(6):490-502. PubMed ID: 10155335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction and validation of a short-form benign prostatic hypertrophy health-related quality-of-life questionnaire. BPH Group in General Practice.
    Lukacs B; Comet D; Grange JC; Thibault P
    Br J Urol; 1997 Nov; 80(5):722-30. PubMed ID: 9393292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.
    Ware J; Kosinski M; Keller SD
    Med Care; 1996 Mar; 34(3):220-33. PubMed ID: 8628042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring health-related quality of life.
    Guyatt GH; Feeny DH; Patrick DL
    Ann Intern Med; 1993 Apr; 118(8):622-9. PubMed ID: 8452328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume.
    Bosch JL; Hop WC; Kirkels WJ; Schröder FH
    Br J Urol; 1995 May; 75(5):622-30. PubMed ID: 7542132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia.
    Fulton B; Wagstaff AJ; Sorkin EM
    Drugs; 1995 Feb; 49(2):295-320. PubMed ID: 7537194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cultural and linguistic validation, in Spanish, of the International Prostatic Symptoms Scale (I-PSS)].
    Vela Navarrete R; Martín Moreno JM; Calahorra FJ; Damián Moreno J; Hernández Coronado A; Boyle P
    Actas Urol Esp; 1994 Sep; 18(8):841-7. PubMed ID: 7527993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of the alpha-1 blocker doxazosin in the treatment of benign prostatic hyperplasia. Analysis of 5 studies. Doxazosin Study Groups.
    Janknegt RA; Chapple CR
    Eur Urol; 1993; 24(3):319-26. PubMed ID: 7505224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferences.
    Barry MJ; Mulley AG; Fowler FJ; Wennberg JW
    JAMA; 1988 May; 259(20):3010-7. PubMed ID: 2452904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association.
    Barry MJ; Fowler FJ; O'Leary MP; Bruskewitz RC; Holtgrewe HL; Mebust WK
    J Urol; 1992 Nov; 148(5):1558-63; discussion 1564. PubMed ID: 1279219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.
    Barry MJ; Fowler FJ; O'Leary MP; Bruskewitz RC; Holtgrewe HL; Mebust WK; Cockett AT
    J Urol; 1992 Nov; 148(5):1549-57; discussion 1564. PubMed ID: 1279218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The Spanish version of the Short Form 36 Health Survey: a decade of experience and new developments].
    Vilagut G; Ferrer M; Rajmil L; Rebollo P; Permanyer-Miralda G; Quintana JM; Santed R; Valderas JM; Ribera A; Domingo-Salvany A; Alonso J
    Gac Sanit; 2005; 19(2):135-50. PubMed ID: 15860162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life and sexuality: methodological aspects.
    O'Leary MP
    Eur Urol; 2001; 40 Suppl 3():13-8. PubMed ID: 11786672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of individual response in symptom score evaluation.
    Desgrandchamps F
    Eur Urol; 2001; 40 Suppl 3():2-7. PubMed ID: 11786670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linguistic adaptation and validation of the Spanish version of the Benign Prostatic Hyperplasia-Patient Impact Measure (BPH-PIM).
    Llorente C; Ruiz M; Rejas Gutiérrez J; Esteban M; Villasante F; Hareendran A
    Clin Drug Investig; 2006; 26(2):103-12. PubMed ID: 17163240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality-of-life assessment in patients with benign prostatic hyperplasia: effects of various interventions.
    Batista-Miranda JE; Diez MD; Bertrán PA; Villavicencio H
    Pharmacoeconomics; 2001; 19(11):1079-90. PubMed ID: 11735675
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.